MAMohammad Faisal Almuaigel

Mohammad Faisal Almuaigel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammad Faisal Almuaigel has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Foziah Jabbar Alshamrani

    Department of Neurology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia

    3 shared publications
  • Noor M. AlMohish

    From the Neurology Department (Alamri, Almuaigel, Alshamrani, Zafar, AlMohish), King Fahad University Hospital, Al Khobar; from the Neurology Department, College of Medicine (Alamri, Alshamrani, Zafar), Imam Abdulrahman Bin Faisal University; and from the Physiology Department (AlSheikh), College of Medicine, Imam Abdulrahman Bin Faisal University, Al Dammam, Kingdom of Saudi Arabia

    3 shared publications
  • Foziah J. Alshamrani

    From the Neurology Department (Alamri, Almuaigel, Alshamrani, Zafar, AlMohish), King Fahad University Hospital, Al Khobar; from the Neurology Department, College of Medicine (Alamri, Alshamrani, Zafar), Imam Abdulrahman Bin Faisal University; and from the Physiology Department (AlSheikh), College of Medicine, Imam Abdulrahman Bin Faisal University, Al Dammam, Kingdom of Saudi Arabia

    2 shared publications
  • Hind Alnajashi

    Department of Neurology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

    2 shared publications
  • Abdulla Alamri

    College of Medicine, Imam Abdulrahman Bin Faisal university, Dammam, Saudi Arabia

    1 shared publication
  • Abdullah A. Alsulaiman

    Department of Neurology, College of Medicine Imam Abdulrahman Bin Faisal University, King Fahad University Hospital, Al Ahsa, Kingdom of Saudi Arabia.

    1 shared publication

Latest Publications

  • Open Access

    Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia

    by Foziah Alshamrani, Hind Alnajashi, Mohammed AlJumah, Mohammad Almuaigel, Yaser Almalik, Seraj Makkawi, Sadiq Alsalman, Mousa Almejally, Shireen Qureshi, Salman Aljarallah, et al.


  • Postprandial fasting related headache during Ramadan in Saudi Arabia: A cross-sectional study

    by Abdullah AlAmri, Mohammed AlMuaigel, Mona AlSheikh, Mohammad Zeeshan, Wejdan Suwayyid, Foziah AlShamrani

    Background: Headache disorders are classified as primary or secondary; however, among the secondary headaches, those attributed to food ingestion are not well understood. Therefore, we conducted this study to describe and characterize a new headache entity that occurred during the holy month of Ramadan. This headache occurred within 4 h of breaking the fast. Methods: This is a nationwide descriptive community-based cross-sectional study conducted during the last 10 days of Ramadan, based on a random sample of adults living in Saudi Arabia. The demographic data, headache symptomatology, nature and distribution of the pain, possible triggering and relieving factors, and patient management programs were analyzed. Results: Completed questionnaires were obtained from 16,031 participants. Of those, 3147 (19.6%) reported headaches after breaking the fast in Ramadan. In 84.1% of cases, there was no previous diagnosis of headache or migraine. The characteristics of these postprandial fasting-related headaches mostly was episodic in nature (72%). The nature of the headache was variable, mostly heaviness or tightness (53.9%). Triggering factors included ingestion of fried food in (45%) and coffee (26.3%). Lying down and sleeping was found to be an important relieving factor (61%). Conclusion: A new headache entity is being described. Appears to be quite common, occurs less than 2 h following the first meal, and is mostly of the heaviness and tension type.


  • Open Access

    Clinical presentations, radiological characteristics, and biological risk factors of cerebral venous thrombosis at a University Hospital in Saudi Arabia

    by Abdullah S. Alamri, Mohammed F. Almuaigel, Zafar Azra, Foziah J. Alshamrani, Noor M. AlMohish, Mona H. AlSheikh

    Objectives: To describe the clinical features and possible etiologies of cerebral vein thrombosis (CVT) in a Saudi Arabian cohort. Methods: A retrospective, observational design was implemented. Data pertaining to 36 patients (19 female and 17 male) with confirmed CVT diagnosis admitted to a hospital in Saudi Arabia between 2008 and 2019 were obtained and analyzed. Results: The age of patients ranged between 19 to 82 years, and the mean/median age was 33/29 years. Most commonly reported symptoms were headache ( 72%), unilateral lower limb weakness (39%), and seizures (17%). Papilledema was found in 8% of patients. Thrombotic disorders were identified in 14% and infections were identified in 8% of the patients. Two patients had ulcerative colitis, 2 were diagnosed with Behcet’s disease, and 2 women were using oral contraceptive pills. Single sinus thrombosis was detected in only 22% of patients. One patient with diabetic ketoacidosis died. Thrombotic disorder was the most common risk factor, followed by that iron deficiency anemia. Conclusion: The transverse sinus was the most frequently thrombosed sinus. Iron deficiency anemia emerged as a predisposing preventable condition for CVT, while genetic factors were found to be less important in this cohort.


  • Open Access

    Epilepsy trigger factors in Saudi Arabia

    by Foziah J. Alshamrani, Mohammed A. Alshurem, Mohammed F. Almuaigel, Noor M. AlMohish

    To identify epilepsy triggers prevalent in Saudi Arabia with a view to seizure prevention or achieving a reduction in their frequency. This is part of a cross-sectional study carried out in 2020 in a Saudi population in the Kingdom of Saudi Arabia (KSA). We used an online questionnaire to evaluate the most common seizure trigger factors. A total of 546 Saudi patients with epilepsy participated in the study, of which 289 (53%) were women. Of them, 263 (48.1%) had no seizure in the previous 3 months. One hundred and thirty-six (25%) had a family member with epilepsy. The most-reported trigger factor was sleep deprivation reported by 285 (52%), followed by stress 225 (41%), missed medication 210 (38.5%), anxiety 209 (38.3%), and fatigue 184 (33.7%). Sleep deprivation is the most reported trigger factor for seizures in the KSA, followed by stress, followed by missed medication.


  • Open Access

    Spontaneous Bilateral Dissection of the Vertebral Artery: A Case Report

    by Aldanah Althwanay, Abdullah Alamri, Mohammed F. Almuaigel

    Spontaneous dissection of the vertebral artery refers to cases that do not involve significant blunt or penetrating trauma as a precipitating factor. However, cases of spontaneous dissection of the vertebral artery do have a history of trivial or minor injury involving some degree of cervical distortion such as chiropractic neck manipulation, as the extreme hyperextension and/or rotation of the neck may create areas of stretch and lead to intimal or adventitial tears in the vertebral artery causing dissection. It is a relatively rare, potentially disabling and sometimes an under-diagnosed cause of stroke. It accounts for 2% of all ischemic strokes and 7% of the cases are bilateral. Herein we present a case of bilateral vertebral artery dissection complicated by basilar artery stroke in a young male patient following chiropractic manipulation of the neck. Neuroimaging modalities upon presentation confirmed the diagnosis. Antiplatelets were administered, and a great clinical outcome after three months was achieved. This report demonstrates the potential hazards associated with neck trauma, including chiropractic manipulation, as it is under reported in Saudi Arabia.


  • Open Access

    Impact of depression and fatigue on relapsing remitting multiple sclerosis in Kingdom of Saudi Arabia

    by Foziah J. Alshamrani, Mohammed F. Almuaigel, Fahd A. Alkhamis, Abdullah A. Alsulaiman, Noor M. AlMohish, Abdullah F. Albuhassah, Anwar S. AlZahrani, Ashraf A. Mahmoud Zaher

    Impact of depression and fatigue on relapsing remitting multiple sclerosis in Kingdom of Saudi Arabia


  • Open Access

    Efficacy and Safety of Intravenous Cladribine in Patients with Rapidly Evolving or Early Secondary Progressive Multiple Sclerosis

    by Foziah Alshamrani, Hind Alnajashi, Mohammed F. Almuaigel

    Background Multiple sclerosis (MS) is an autoimmune and demyelinating inflammatory disease that affects the central nervous system (CNS). The etiology of the disease remains unknown. Multiple theories highlight genetic, environmental, and infectious factors that may a role. MS is considered as the main cause of disability in young people. Cladribine, known chemically as (2-Chloro-2′-deoxyadenosine), is a purine analog chemotherapy used for hairy cell leukemia and other B-cell lymphomas. The goal of this study was to evaluate the safety and efficacy of cladribine in patients with rapidly evolving or early secondary progressive MS. Methods This observational, single-center, retrospective chart review at the MS Clinic in the Ottawa General Hospital, Ottawa, Canada. A total of 24 patients (median Expanded Disability Status Scale (EDSS) of 4.5) received cladribine (0.07 mg/kg/day) for four consecutive days every six months for ≥ 2 cycles with further cycles depending on lymphocyte recovery or disease activity to a maximum of eight cycles from 2005 until 2016 were included. Four patients who were already diagnosed with rapidly evolving or early secondary progressive multiple sclerosis (SPMS) were induced with cladribine. We evaluated relapse, EDSS, and magnetic resonance imaging (MRI) results. Results Out of 24 patients (ages ranging from 30 - 60), 80% were female. Median follow-up time was seven years. The mean relapse rate in the two years before patients were given cladribine was 1.25. Twenty patients had previously received multiple disease-modifying therapies (DMTs) (≥ 2) prior to receiving cladribine. Following cladribine, eight patients suffered 10 relapses (33.3% of the cohort). Annualized relapse rates (ARRs) were reduced from 1.25 to 0.42, which was statistically significant (p-value = 0.002). There was no mean difference in EDSS (p-value = 0.06): 16% deteriorated, 62% did not change, and 12.5% improved. New MRI activity (new T2 or Gad+ lesions) was noted in only seven of 24 patients. Conclusion Parenteral cladribine reduced the relapse rate from 1.25 to 0.42, which was statistically significant (p-value = 0.002). MRI activity in patients with rapidly evolving or early secondary progressive multiple sclerosis had a reasonable safety profile.


  • Open Access

    COVID19 Infection in Children: A Narrative Review

    by Mohammed Almuaigel, Ali Alfuraidan, Abdulrahman Alhulaybi, Amro Althuwayqib, Khalifah Alfarhan, Fahad Aldossary, Hussain Alturki, Abdullah Althani, Mohammed Alismail, Mohamed AlOtaibi, et al.

    Coronavirus disease 2019 (COVID-19) was named by the WHO as a pandemic disease. The aim is to review recent studies regarding COVID 19 infection in childhood in terms of the clinical features, need for critical care and mortality. Most pediatrics become infected from close contacts and then act as a virus carrier to others. The infected children are mainly asymptomatic, but unfortunately when symptomatic they an overlap with other common pediatric respiratory illnesses. Symptoms in pediatrics are mainly fever with pharyngitis, bronchitis and less likely inferior respiratory tract infections. Most pediatric patients recover well with minimal symptomatic and supportive therapy.

  • Disseminated nocardiosis in a female patient with idiopathic thrombocytopenic purpura: A case report

    by Alshamrani Foziah, Almuaigel Mohammed, AlMohish Noor, Turkistani Leenah, Alghanimi Ibrahim, Aljubran Saeed, Al-Muhanna Afnan


  • Open Access

    Case Study: Supporting Students with an Autistics Spectrum Disorder

    by Doaa Faisal Almuaigel, Mohammed Faisal Almuaigel

    Case Study: Supporting Students with an Autistics Spectrum Disorder